Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 2
2014 1
2015 1
2018 1
2020 3
2021 4
2022 5
2023 8
2024 3
2025 6
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025.
Rose AM, Lucaccioni H, Marsh K, Kirsebom F, Whitaker H, Emborg HD, Bolt Botnen A, O'Doherty MG, Pozo F, Hameed SS, Andrews N, Hamilton M, Trebbien R, Lauenborg Møller K, Marques DF, Murphy S, McQueenie R, Lopez-Bernal J, Cottrell S, Bucholc M, Kissling E; European IVE group; Members of the European IVE group. Rose AM, et al. Euro Surveill. 2025 Feb;30(7):2500102. doi: 10.2807/1560-7917.ES.2025.30.7.2500102. Euro Surveill. 2025. PMID: 39980423 Free PMC article.
Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025.
Savulescu C, Ganser I, Nicolay N, Lajot A, Campos S, Martínez-Baz I, Rodrigues AP, Vandromme M, Cara-Rodríguez M, Echeverría A, Gaio V, Parsy MP, Roldan Garrido A, Castilla J, Guiomar R, Bacci S, Rose AM; VEBIS hospital network RSV IE group. Savulescu C, et al. Euro Surveill. 2025 Nov;30(45):2500816. doi: 10.2807/1560-7917.ES.2025.30.45.2500816. Euro Surveill. 2025. PMID: 41234196 Free PMC article.
National real-life impact of prevention with nirsevimab on infants' RSV hospitalizations in Belgium.
Blumental S, Lajot A, Vandromme M, Lafort Y, Dockx Y, Denayer S, Wampers A, Nebbioso A, Tilmanne A, Mignon C, Tuerlinckx D, Rigolle H, Matthijs I, Vandersnickt J, Hellinckx J, Dewulf J, Coppens K, Van Hoorenbeeck K, Vanlede K, Winters L, Seyler L, Parsy MP, Reynders M, Balcaen M, Urbina M, Dauby N, Chatzis O, Naesens R, Dorval S, Ternest S, Vanspeybroeck S, Goetghebuer T, Van Ackere T, Selimaj Kontoni V, El Bitar W, Holemans X, Bruyere Y, Van Brusselen D, De Mot L, Raes M. Blumental S, et al. Among authors: seyler l. BMC Infect Dis. 2026 May 20. doi: 10.1186/s12879-026-13419-y. Online ahead of print. BMC Infect Dis. 2026. PMID: 42163123 Free article.
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026.
Lucaccioni H, Marques DF, Kirsebom F, Emborg HD, Hamilton M, Whitaker H, Bolt Botnen A, Bucholc M, Pozo F, Andrews N, Trebbien R, Hameed SS, Lauenborg Møller K, O'Doherty MG, Lopez-Bernal J, Morrison K, Cottrell S, Wilton S, Rose AM, Kissling E; European IVE group. Lucaccioni H, et al. Euro Surveill. 2026 Feb;31(7):2600109. doi: 10.2807/1560-7917.ES.2026.31.7.2600109. Euro Surveill. 2026. PMID: 41716088 Free PMC article.
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.
Antunes L, Rojas-Castro M, Lozano M, Martínez-Baz I, Leroux-Roels I, Borg ML, Oroszi B, Fitzgerald M, Dürrwald R, Jancoriene L, Machado A, Petrović G, Lazar M, Součková L, Bacci S, Howard J, Verdasca N, Basile L, Castilla J, Ternest S, Džiugytė A, Túri G, Duffy R, Hackmann C, Kuliese M, Gomez V, Makarić ZL, Marin A, Husa P, Nicolay N, Rose AMC; VEBIS SARI VE network team. Antunes L, et al. Influenza Other Respir Viruses. 2025 Mar;19(3):e70081. doi: 10.1111/irv.70081. Influenza Other Respir Viruses. 2025. PMID: 40059069 Free PMC article.
Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC).
Pesonel E, Laouénan C, Guiraud L, Bourner J, Hoffmann I, Molino D, Tardivon C, Bachelet D, Mentré F, Amstutz A, Merson L, Rojek A, Cervantes Gonzalez M, Antinori A, Castagna A, Nozza S, Pourcher V, Libois A, Dunning J, Tacconelli E, Hites M, De La Calle Prieto F, Horby P, Yazdanpanah Y, Calmy A, Lescure FX, Olliaro P; Mpox ObServAtIonal Cohort (MOSAIC) Study Group. Pesonel E, et al. Clin Infect Dis. 2025 Jun 4;80(5):1060-1073. doi: 10.1093/cid/ciae657. Clin Infect Dis. 2025. PMID: 39749987 Free PMC article.
Current challenges in the treatment of HIV.
Seyler L, Lacor P, Allard SD. Seyler L, et al. Pol Arch Intern Med. 2018 Oct 31;128(10):609-616. doi: 10.20452/pamw.4357. Epub 2018 Oct 31. Pol Arch Intern Med. 2018. PMID: 30387448 Free article. Review.
A public health value-based healthcare paradigm for HIV.
Vermeersch S, Demeester RP, Ausselet N, Callens S, De Munter P, Florence E, Goffard JC, Henrard S, Lacor P, Messiaen P, Libois A, Seyler L, Uurlings F, Vandecasteele SJ, Van Wijngaerden E, Yombi JC, Annemans L, De Wit S. Vermeersch S, et al. Among authors: seyler l. BMC Health Serv Res. 2022 Jan 2;22(1):13. doi: 10.1186/s12913-021-07371-7. BMC Health Serv Res. 2022. PMID: 34974833 Free PMC article.
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
Devos T, Van Thillo Q, Compernolle V, Najdovski T, Romano M, Dauby N, Jadot L, Leys M, Maillart E, Loof S, Seyler L, Moonen M, Moutschen M, Van Regenmortel N, Ariën KK, Barbezange C, Betrains A, Garigliany M, Engelen MM, Gyselinck I, Maes P, Schauwvlieghe A, Liesenborghs L, Belmans A, Verhamme P, Meyfroidt G; DAWn-plasma investigators. Devos T, et al. Among authors: seyler l. Eur Respir J. 2022 Feb 10;59(2):2101724. doi: 10.1183/13993003.01724-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 34446469 Free PMC article. Clinical Trial.
Genomic monitoring of SARS-CoV-2 variants using sentinel SARI hospital surveillance.
Denayer S, Dufrasne FE, Monsieurs B, van Eycken R, Houben S, Seyler L, Demuyser T, van Nedervelde E, Bourgeois M, Delaere B, Magerman K, Jouck D, Lissoir B, Sion C, Reynders M, Petit E, Dauby N, Hainaut M, Laenen L, Maes P, Baele G, Dellicour S, Cuypers L, André E, Couvreur S, Brondeel R, Barbezange C, Bossuyt N, van Gucht S. Denayer S, et al. Among authors: seyler l. Influenza Other Respir Viruses. 2023 Oct 13;17(10):e13202. doi: 10.1111/irv.13202. eCollection 2023 Oct. Influenza Other Respir Viruses. 2023. PMID: 37840842 Free PMC article.
37 results